4//SEC Filing
Dawson Michael John 4
Accession 0001209191-22-011853
CIK 0001357459other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 5:54 PM ET
Size
5.6 KB
Accession
0001209191-22-011853
Insider Transaction Report
Form 4
Dawson Michael John
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-02-17+32,400→ 32,400 totalExercise: $0.95Exp: 2032-02-16→ Common Stock (32,400 underlying)
Footnotes (1)
- [F1]1/12th of the shares underlying the Stock Option shall vest and become exercisable on each three-month anniversary of the vesting commencement date and if there is no corresponding day, the last day of the month.
Documents
Issuer
PALISADE BIO, INC.
CIK 0001357459
Entity typeother
Related Parties
1- filerCIK 0001849790
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 5:54 PM ET
- Size
- 5.6 KB